News

Industry news focusing on the people and organizations who work in the clinical trials profession.

As pair of initiatives show, the clinical trials community in Europe is working harder to get its message across to its key partner: patients.

When examining the frequency in use of keywords related to cancer research, some important trends emerge.

Despite guidances and rules advising sponsors to include all demographic groups in clinical trials, many subgroups remain underrepresented.

S

Sites: Making a Difference in Cancer Trials Accrual Trial Design: Oncology Trial Comparator Drug Reimbursement Also in this issue: Singular Approach to Combination Trials Risk Sharing and Interrupted Drug Development Cardio-Oncology: A New Clinical Discipline

Acquisition enhances ICON?s capabilities in adaptive and medical device trials and in Japan

ICON announced its intention to acquire Aptiv Solutions

In January 2013, FDA told manufacturers to lower the dose of zolpidem for women

With the European Union's new rules on clinical trials?including data access?approaching their final legislative stage, and the European Medicines Agency planning to announce its new rules on data disclosure within weeks, the European drug industry is still running to catch up with transparency issues.

More than half of biopharmaceutical companies surveyed use a Strategic Partnership model

EFPIA announced an update on industry progress made on the EFPIA-PhRMA Principles for Responsible Clinical Trials Data Sharing.

EFPIA has issued a new statement on the EFPIA-PhRMA Principles for Responsible Clinical Trials Data Sharing

An independent Data and Safety Monitoring Board has completed the successful review of the safety data of the Phase IIb clinical trial of TNF-Kinoid in rheumatoid arthritis

Camargo Pharmaceutical Services has tapped academic organizations close to its Raleigh, NC site in a unique internship program...

With the joint release and agreement of the PhRMA and EFPIA on those organizations clinical trial data sharing and transparency principles, BIO has releases its own Principles on Clinical Trial Data Sharing.

Medesis Pharma has signed a collaboration agreement with the French Commission for Atomic Energy and Alternative Energies

Innovative partner network to facilitate integration of digital patient engagement and data capture in clinical research programs

Camargo Pharmaceutical Services is adding expertise to its projects and helping postdoctoral researchers gain real-world experience through a unique internship program.

I've notice of late quite of lot of confusion over the approval requirements that apply when using mobile devices in clinical trials.

The Biotechnology Industry Organization today reaffirmed and broadened its long-standing commitment to improving human health...

NEOVACS announced its financial results for the year to 31 December 2013 as approved by the Board of Directors on March 26th 2014.

Novel scientific collaboration to use genomics and big data to drive drug discovery

MedNet will once again be participating in the Partnerships in Clinical Trials conference.

A public-private research initiative between GSK, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute aims to harness the power of "big data" and genome sequencing to improve the success rate for discovering new medicines.

As payers demand more evidence documenting medical product value, biopharma companies are responding by moving sooner to decide key clinical outcomes to measure.

The global orphan drugs market presents many opportunities for new drug development...

PCORI has appointed 10 members to its new Advisory Panel on Clinical Trials

PCORI has launched its Matchmaking App Challenge

Panel Will Provide Expertise on Trial Selection, Design and Implementation